← back to search

Moupali Das

Gilead Sciences (United States) · US
Area of research
Infectious Diseases · Emergency Medicine
Research interest
Research interests include HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV-related health complications and treatments, and HIV Research and Treatment.
h-index
33
citations
5,423
works
98
NIH funding
primary concept
Medicine
email

Recent publications

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons
New England Journal of Medicine 2024cited by 206position: middledoi
HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women
JAMA 2024cited by 71position: middledoi
Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies
Clinical Infectious Diseases 2024cited by 18position: middledoi
Proactive strategies to optimize engagement of Black, Hispanic/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP)
PLoS ONE 2022cited by 40position: middledoi
Compassionate Use of Remdesivir in Children With Severe COVID-19
PEDIATRICS 2021cited by 103position: middledoi
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial
The Lancet 2020cited by 418position: middledoi
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
Clinical Infectious Diseases 2020cited by 120position: middledoi
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials
Clinical Infectious Diseases 2019cited by 737position: middledoi
The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus–Infected Patients in 11 US Cities
Clinical Infectious Diseases 2018cited by 21position: middledoi
Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use
JAMA 2016cited by 193position: middledoi
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy
JAIDS Journal of Acquired Immune Deficiency Syndromes 2015cited by 140position: middledoi
Effect of Risk-Reduction Counseling With Rapid HIV Testing on Risk of Acquiring Sexually Transmitted Infections
JAMA 2013cited by 127position: middledoi
Dose-Response Associations Between Number and Frequency of Substance Use and High-Risk Sexual Behaviors Among HIV-Negative Substance-Using Men Who Have Sex With Men (SUMSM) in San Francisco
JAIDS Journal of Acquired Immune Deficiency Syndromes 2013cited by 78position: middledoi
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double‐blind, placebo‐controlled trial
Addiction 2012cited by 65position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christoph C Carter · Gilead Sciences (United States)4 papers (2019–2024) · 3 papers (2012–2013)Grant Colfax · San Francisco Department of Public Health3 papers (2012–2013)Diana M. Brainard · Gilead Sciences (France)3 papers (2019–2021)Lijie Zhong · Jiangxi University of Traditional Chinese Medicine2 papers (2019–2020)Christian Callebaut · Gilead Sciences (United States)2 papers (2015–2020)Huyen Cao · Public Health Dayton & Montgomery County2 papers (2015–2021)Lauren Gooden · City University of New York2 papers (2013–2018)Karam Mounzer · Penn Presbyterian Medical Center2 papers (2020–2022)Daniel J. Feaster · University of Miami2 papers (2013–2018)Glenn‐Milo Santos · University of California, San Francisco2 papers (2012–2013) · 2 papers (2012–2013)Scott McCallister · Gilead Sciences (United States)2 papers (2015–2020)Eric Vittinghoff · University of California, San Francisco2 papers (2012–2013)Raúl N. Mandler · University of New Mexico2 papers (2013–2018)Phillip O. Coffin · University of California, San Francisco2 papers (2012–2013)Jared M. Baeten · University of Washington2 papers (2022–2024)Frank A. Post · King's College Hospital NHS Foundation Trust2 papers (2019–2020)Lisa R. Metsch · University of Miami2 papers (2013–2018)Stefan Eßer · Essen University Hospital1 papers (2019–2019)